BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai Z, Liu X, Guan Q, Ding N, Wei Q, Tong B, Zhao M, Zhang W, Ma L. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells. Chem Biol Interact 2020;315:108886. [PMID: 31682804 DOI: 10.1016/j.cbi.2019.108886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Li F, Huang T, Tang Y, Li Q, Wang J, Cheng X, Zhang W, Zhang B, Zhou C, Tu S. Utidelone inhibits growth of colorectal cancer cells through ROS/JNK signaling pathway. Cell Death Dis 2021;12:338. [PMID: 33795638 DOI: 10.1038/s41419-021-03619-6] [Reference Citation Analysis]
2 Amewu RK, Sakyi PO, Osei-Safo D, Addae-Mensah I. Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological Targets. Molecules 2021;26:7134. [PMID: 34885716 DOI: 10.3390/molecules26237134] [Reference Citation Analysis]
3 Sharma P, LaRosa C, Antwi J, Govindarajan R, Werbovetz KA. Imidazoles as Potential Anticancer Agents: An Update on Recent Studies. Molecules 2021;26:4213. [PMID: 34299488 DOI: 10.3390/molecules26144213] [Reference Citation Analysis]
4 Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat 2021;55:100754. [PMID: 33691261 DOI: 10.1016/j.drup.2021.100754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Bai Z, Zhou Q, Zhu H, Ye X, Wu P, Ma L. QTMP, a Novel Thiourea Polymer, Causes DNA Damage to Exert Anticancer Activity and Overcome Multidrug Resistance in Colorectal Cancer Cells. Front Oncol 2021;11:667689. [PMID: 34123833 DOI: 10.3389/fonc.2021.667689] [Reference Citation Analysis]
6 Gangapuram M, Mazzio EA, Redda KK, Soliman KFA. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel. Int J Mol Sci 2021;22:7694. [PMID: 34299315 DOI: 10.3390/ijms22147694] [Reference Citation Analysis]